TreeWAS – Variant ID: rs75108997

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
Chapter II Neoplasms	0.059	0.941
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.057	0.943
C50-C50 Malignant neoplasm of breast	0.056	0.944
C50 Malignant neoplasm of breast	0.055	0.945
C50.9 Breast, unspecified	0.052	0.948
C79 Secondary malignant neoplasm of other sites	0.051	0.949
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.050	0.950
C43-C44 Melanoma and other malignant neoplasms of skin	0.048	0.952
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.048	0.952
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.047	0.953
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.047	0.953
C50.5 Lower-outer quadrant of breast	0.047	0.953
C80 Malignant neoplasm without specification of site	0.047	0.953
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.046	0.954
C15-C26 Malignant neoplasms of digestive organs	0.046	0.954
D37-D48 Neoplasms of uncertain or unknown behaviour	0.045	0.955
# Top node	0.044	0.956
C77.0 Lymph nodes of head, face and neck	0.043	0.957
C60-C63 Malignant neoplasms of male genital organs	0.043	0.957
C51-C58 Malignant neoplasms of female genital organs	0.043	0.957
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.043	0.957
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.043	0.957
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.043	0.957
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.043	0.957
C40-C41 Malignant neoplasms of bone and articular cartilage	0.043	0.957
C64-C68 Malignant neoplasms of urinary tract	0.042	0.958
C50.2 Upper-inner quadrant of breast	0.042	0.958
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.042	0.958
D00-D09 In situ neoplasms	0.041	0.958
C76 Malignant neoplasm of other and ill-defined sites	0.041	0.959
C77.1 Intrathoracic lymph nodes	0.041	0.959
Chapter XII Diseases of the skin and subcutaneous tissue	0.041	0.959
C50.8 Overlapping lesion of breast	0.039	0.960
C50.6 Axillary tail of breast	0.039	0.960
C50.3 Lower-inner quadrant of breast	0.039	0.960
C50.1 Central portion of breast	0.039	0.960
C50.0 Nipple and areola	0.039	0.960
C50.4 Upper-outer quadrant of breast	0.039	0.961
C80.9 Malignant neoplasm, unspecified	0.039	0.961
C09 Malignant neoplasm of tonsil	0.038	0.961
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.038	0.961
D10-D36 Benign neoplasms	0.038	0.962
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.038	0.962
C34 Malignant neoplasm of bronchus and lung	0.038	0.962
Chapter VII Diseases of the eye and adnexa	0.038	0.962
C43 Malignant melanoma of skin	0.038	0.962
C44 Other malignant neoplasms of skin	0.038	0.962
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.037	0.963
C83 Diffuse non-Hodgkin's lymphoma	0.037	0.963
C79.9 Secondary malignant neoplasm, unspecified site	0.037	0.963
C79.8 Secondary malignant neoplasm of other specified sites	0.037	0.963
C79.7 Secondary malignant neoplasm of adrenal gland	0.037	0.963
C79.6 Secondary malignant neoplasm of ovary	0.037	0.963
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.037	0.963
C79.2 Secondary malignant neoplasm of skin	0.037	0.963
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.037	0.963
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.037	0.963
Chapter VI Diseases of the nervous system	0.037	0.963
C77.9 Lymph node, unspecified	0.036	0.964
C77.8 Lymph nodes of multiple regions	0.036	0.964
C77.5 Intrapelvic lymph nodes	0.036	0.964
C77.4 Inguinal and lower limb lymph nodes	0.036	0.964
Chapter VIII Diseases of the ear and mastoid process	0.036	0.964
C77.3 Axillary and upper limb lymph nodes	0.036	0.964
Chapter V Mental and behavioural disorders	0.036	0.964
C20 Malignant neoplasm of rectum	0.035	0.964
C19 Malignant neoplasm of rectosigmoid junction	0.035	0.965
Chapter X Diseases of the respiratory system	0.035	0.965
L80-L99 Other disorders of the skin and subcutaneous tissue	0.035	0.965
L00-L08 Infections of the skin and subcutaneous tissue	0.035	0.965
C77.2 Intra-abdominal lymph nodes	0.035	0.965
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.034	0.966
C95 Leukaemia of unspecified cell type	0.034	0.966
C94 Other leukaemias of specified cell type	0.034	0.966
C93 Monocytic leukaemia	0.034	0.966
C92 Myeloid leukaemia	0.034	0.966
C91 Lymphoid leukaemia	0.034	0.966
C90 Multiple myeloma and malignant plasma cell neoplasms	0.034	0.966
C88 Malignant immunoproliferative diseases	0.034	0.966
C86 Other specified types of T/NK-cell lymphoma	0.034	0.966
C84 Peripheral and cutaneous T-cell lymphomas	0.034	0.966
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.034	0.966
C81 Hodgkin's disease	0.034	0.966
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.034	0.966
Chapter IX Diseases of the circulatory system	0.034	0.966
D60-D64 Aplastic and other anaemias	0.034	0.966
L20-L30 Dermatitis and eczema	0.034	0.966
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.034	0.966
C13 Malignant neoplasm of hypopharynx	0.034	0.966
C11 Malignant neoplasm of nasopharynx	0.034	0.966
C10 Malignant neoplasm of oropharynx	0.034	0.966
C08 Malignant neoplasm of other and unspecified major salivary glands	0.034	0.966
C06 Malignant neoplasm of other and unspecified parts of mouth	0.034	0.966
C05 Malignant neoplasm of palate	0.034	0.966
C04 Malignant neoplasm of floor of mouth	0.034	0.966
C03 Malignant neoplasm of gum	0.034	0.966
C02 Malignant neoplasm of other and unspecified parts of tongue	0.034	0.966
C00 Malignant neoplasm of lip	0.034	0.966
C12 Malignant neoplasm of pyriform sinus	0.034	0.966
C07 Malignant neoplasm of parotid gland	0.034	0.966
C01 Malignant neoplasm of base of tongue	0.034	0.966
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.034	0.966
C38 Malignant neoplasm of heart, mediastinum and pleura	0.034	0.966
C32 Malignant neoplasm of larynx	0.034	0.966
C31 Malignant neoplasm of accessory sinuses	0.034	0.966
C30 Malignant neoplasm of nasal cavity and middle ear	0.034	0.966
C37 Malignant neoplasm of thymus	0.034	0.966
C33 Malignant neoplasm of trachea	0.034	0.966
C80.0 Malignant neoplasm, primary site unknown, so stated	0.034	0.966
C78.0 Secondary malignant neoplasm of lung	0.034	0.966
D22 Melanocytic naevi	0.033	0.966
H25-H28 Disorders of lens	0.033	0.967
C26 Malignant neoplasm of other and ill-defined digestive organs	0.033	0.967
C25 Malignant neoplasm of pancreas	0.033	0.967
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.033	0.967
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.033	0.967
C21 Malignant neoplasm of anus and anal canal	0.033	0.967
C17 Malignant neoplasm of small intestine	0.033	0.967
C16 Malignant neoplasm of stomach	0.033	0.967
C15 Malignant neoplasm of oesophagus	0.033	0.967
C23 Malignant neoplasm of gallbladder	0.033	0.967
J30-J39 Other diseases of upper respiratory tract	0.033	0.967
Chapter XV Pregnancy, childbirth and the puerperium	0.032	0.967
G50-G59 Nerve, nerve root and plexus disorders	0.032	0.968
C09.9 Tonsil, unspecified	0.032	0.968
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.032	0.968
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.032	0.968
D46 Myelodysplastic syndromes	0.032	0.968
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.032	0.968
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.032	0.968
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.032	0.968
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.032	0.968
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.032	0.968
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.032	0.968
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.032	0.968
D45 Polycythaemia vera	0.032	0.968
C34.9 Bronchus or lung, unspecified	0.032	0.968
D64 Other anaemias	0.032	0.968
C56 Malignant neoplasm of ovary	0.031	0.968
I30-I52 Other forms of heart disease	0.032	0.968
C61 Malignant neoplasm of prostate	0.032	0.968
Chapter XXII Codes for special purposes	0.031	0.968
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.031	0.968
Chapter XVI Certain conditions originating in the perinatal period	0.031	0.968
L97 Ulcer of lower limb, not elsewhere classified	0.031	0.969
C18 Malignant neoplasm of colon	0.031	0.969
Z51 Other medical care	0.031	0.969
C64 Malignant neoplasm of kidney, except renal pelvis	0.031	0.969
C63 Malignant neoplasm of other and unspecified male genital organs	0.031	0.969
C62 Malignant neoplasm of testis	0.031	0.969
C60 Malignant neoplasm of penis	0.031	0.969
C57 Malignant neoplasm of other and unspecified female genital organs	0.031	0.969
C53 Malignant neoplasm of cervix uteri	0.031	0.969
C51 Malignant neoplasm of vulva	0.031	0.969
C58 Malignant neoplasm of placenta	0.031	0.969
C55 Malignant neoplasm of uterus, part unspecified	0.031	0.969
C52 Malignant neoplasm of vagina	0.031	0.969
L50-L54 Urticaria and erythema	0.031	0.969
C54 Malignant neoplasm of corpus uteri	0.031	0.969
Z40-Z54 Persons encountering health services for specific procedures and health care	0.031	0.969
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.031	0.969
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.031	0.969
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.031	0.969
C49 Malignant neoplasm of other connective and soft tissue	0.031	0.969
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.031	0.969
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.031	0.969
C46 Kaposi's sarcoma	0.031	0.969
C45 Mesothelioma	0.031	0.969
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.031	0.969
C71 Malignant neoplasm of brain	0.031	0.969
C70 Malignant neoplasm of meninges	0.031	0.969
C69 Malignant neoplasm of eye and adnexa	0.031	0.969
C75 Malignant neoplasm of other endocrine glands and related structures	0.031	0.969
C74 Malignant neoplasm of adrenal gland	0.031	0.969
C73 Malignant neoplasm of thyroid gland	0.031	0.969
C97 Malignant neoplasms of independent (primary) multiple sites	0.031	0.969
H90-H95 Other disorders of ear	0.031	0.969
C68 Malignant neoplasm of other and unspecified urinary organs	0.030	0.969
C66 Malignant neoplasm of ureter	0.030	0.969
C65 Malignant neoplasm of renal pelvis	0.030	0.969
H53-H54 Visual disturbances and blindness	0.030	0.969
H40-H42 Glaucoma	0.030	0.969
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.030	0.969
C44.4 Skin of scalp and neck	0.030	0.970
C43.7 Malignant melanoma of lower limb, including hip	0.030	0.970
L03 Cellulitis	0.030	0.970
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.030	0.970
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.030	0.970
C78.4 Secondary malignant neoplasm of small intestine	0.030	0.970
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.030	0.970
C78.2 Secondary malignant neoplasm of pleura	0.030	0.970
C78.1 Secondary malignant neoplasm of mediastinum	0.030	0.970
Z51.1 Chemotherapy session for neoplasm	0.030	0.970
D64.9 Anaemia, unspecified	0.030	0.970
D09 Carcinoma in situ of other and unspecified sites	0.030	0.970
D07 Carcinoma in situ of other and unspecified genital organs	0.030	0.970
D06 Carcinoma in situ of cervix uteri	0.030	0.970
D04 Carcinoma in situ of skin	0.030	0.970
D03 Melanoma in situ	0.030	0.970
D02 Carcinoma in situ of middle ear and respiratory system	0.030	0.970
D01 Carcinoma in situ of other and unspecified digestive organs	0.030	0.970
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.030	0.970
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.030	0.970
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.030	0.970
C76.8 Overlapping lesion of other and ill-defined sites	0.030	0.970
C76.7 Other ill-defined sites	0.030	0.970
C76.5 Lower limb	0.030	0.970
C76.4 Upper limb	0.030	0.970
C76.3 Pelvis	0.030	0.970
C76.2 Abdomen	0.030	0.970
C76.1 Thorax	0.030	0.970
C76.0 Head, face and neck	0.030	0.970
C44.1 Skin of eyelid, including canthus	0.030	0.970
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.030	0.970
L30 Other dermatitis	0.030	0.970
C83.3 Large cell (diffuse)	0.029	0.970
C67 Malignant neoplasm of bladder	0.029	0.970
D27 Benign neoplasm of ovary	0.030	0.970
L10-L14 Bullous disorders	0.029	0.971
I47 Paroxysmal tachycardia	0.029	0.971
Chapter XXI Factors influencing health status and contact with health services	0.029	0.971
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified	0.029	0.971
D05 Carcinoma in situ of breast	0.029	0.971
L60-L75 Disorders of skin appendages	0.029	0.971
I60-I69 Cerebrovascular diseases	0.029	0.971
L90 Atrophic disorders of skin	0.029	0.971
D70-D77 Other diseases of blood and blood-forming organs	0.028	0.972
H43-H45 Disorders of vitreous body and globe	0.028	0.972
C44.7 Skin of lower limb, including hip	0.028	0.972
Chapter I Certain infectious and parasitic diseases	0.028	0.972
D22.5 Melanocytic naevi of trunk	0.028	0.972
C09.8 Overlapping lesion of tonsil	0.028	0.972
C09.1 Tonsillar pillar (anterior) (posterior)	0.028	0.972
C09.0 Tonsillar fossa	0.028	0.972
Z51.0 Radiotherapy session	0.028	0.972
J34 Other disorders of nose and nasal sinuses	0.028	0.972
D36 Benign neoplasm of other and unspecified sites	0.028	0.972
D35 Benign neoplasm of other and unspecified endocrine glands	0.028	0.972
D33 Benign neoplasm of brain and other parts of central nervous system	0.028	0.972
D32 Benign neoplasm of meninges	0.028	0.972
D31 Benign neoplasm of eye and adnexa	0.028	0.972
D30 Benign neoplasm of urinary organs	0.028	0.972
D29 Benign neoplasm of male genital organs	0.028	0.972
D28 Benign neoplasm of other and unspecified female genital organs	0.028	0.972
D26 Other benign neoplasms of uterus	0.028	0.972
D21 Other benign neoplasms of connective and other soft tissue	0.028	0.972
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.028	0.972
D19 Benign neoplasm of mesothelial tissue	0.028	0.972
D16 Benign neoplasm of bone and articular cartilage	0.028	0.972
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.028	0.972
D14 Benign neoplasm of middle ear and respiratory system	0.028	0.972
D11 Benign neoplasm of major salivary glands	0.028	0.972
D10 Benign neoplasm of mouth and pharynx	0.028	0.972
D34 Benign neoplasm of thyroid gland	0.028	0.972
F00-F09 Organic, including symptomatic, mental disorders	0.028	0.972
G56 Mononeuropathies of upper limb	0.028	0.972
D80-D89 Certain disorders involving the immune mechanism	0.028	0.972
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.028	0.972
D55-D59 Haemolytic anaemias	0.028	0.972
H25 Senile cataract	0.028	0.972
D23 Other benign neoplasms of skin	0.028	0.972
C34.8 Overlapping lesion of bronchus and lung	0.027	0.972
C34.3 Lower lobe, bronchus or lung	0.027	0.972
C34.2 Middle lobe, bronchus or lung	0.027	0.972
C34.1 Upper lobe, bronchus or lung	0.027	0.972
C34.0 Main bronchus	0.027	0.972
D22.3 Melanocytic naevi of other and unspecified parts of face	0.028	0.972
H26 Other cataract	0.028	0.972
H55-H59 Other disorders of eye and adnexa	0.027	0.972
H46-H48 Disorders of optic nerve and visual pathways	0.027	0.972
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.027	0.972
H10-H13 Disorders of conjunctiva	0.027	0.972
D50-D53 Nutritional anaemias	0.027	0.972
G40-G47 Episodic and paroxysmal disorders	0.027	0.973
C43.9 Malignant melanoma of skin, unspecified	0.027	0.973
C43.8 Overlapping malignant melanoma of skin	0.027	0.973
C43.6 Malignant melanoma of upper limb, including shoulder	0.027	0.973
C43.5 Malignant melanoma of trunk	0.027	0.973
C43.4 Malignant melanoma of scalp and neck	0.027	0.973
C43.3 Malignant melanoma of other and unspecified parts of face	0.027	0.973
C43.2 Malignant melanoma of ear and external auricular canal	0.027	0.973
C43.1 Malignant melanoma of eyelid, including canthus	0.027	0.973
C43.0 Malignant melanoma of lip	0.027	0.973
C44.9 Malignant neoplasm of skin, unspecified	0.027	0.973
C44.8 Overlapping lesion of skin	0.027	0.973
C44.2 Skin of ear and external auricular canal	0.027	0.973
C44.0 Skin of lip	0.027	0.973
I47.2 Ventricular tachycardia	0.027	0.973
Chapter XX External causes of morbidity and mortality	0.027	0.973
D41.4 Bladder	0.027	0.973
C85.7 Other specified types of non-Hodgkin's lymphoma	0.027	0.973
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.027	0.973
C85.1 B-cell lymphoma, unspecified	0.027	0.973
C85.0 Lymphosarcoma	0.027	0.973
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.027	0.973
J33 Nasal polyp	0.027	0.973
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.027	0.973
C44.3 Skin of other and unspecified parts of face	0.027	0.973
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.027	0.973
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.027	0.973
C83.7 Burkitt's tumour	0.027	0.973
C83.6 Undifferentiated (diffuse)	0.027	0.973
C83.5 Lymphoblastic (diffuse)	0.027	0.973
C83.4 Immunoblastic (diffuse)	0.027	0.973
C83.2 Mixed small and large cell (diffuse)	0.027	0.973
C83.1 Small cleaved cell (diffuse)	0.027	0.973
C83.0 Small cell (diffuse)	0.027	0.973
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.027	0.973
H91 Other hearing loss	0.027	0.973
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.027	0.973
L40-L45 Papulosquamous disorders	0.026	0.973
G90-G99 Other disorders of the nervous system	0.027	0.973
G70-G73 Diseases of myoneural junction and muscle	0.027	0.973
G30-G32 Other degenerative diseases of the nervous system	0.027	0.973
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.027	0.973
G00-G09 Inflammatory diseases of the central nervous system	0.027	0.973
D17 Benign lipomatous neoplasm	0.026	0.973
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.026	0.973
J90-J94 Other diseases of pleura	0.026	0.973
G35-G37 Demyelinating diseases of the central nervous system	0.026	0.973
L30.9 Dermatitis, unspecified	0.026	0.974
G20-G26 Extrapyramidal and movement disorders	0.026	0.974
C44.6 Skin of upper limb, including shoulder	0.026	0.974
J20-J22 Other acute lower respiratory infections	0.026	0.974
J00-J06 Acute upper respiratory infections	0.026	0.974
F30-F39 Mood [affective] disorders	0.026	0.974
H80-H83 Diseases of inner ear	0.026	0.974
H65-H75 Diseases of middle ear and mastoid	0.026	0.974
H60-H62 Diseases of external ear	0.026	0.974
L02 Cutaneous abscess, furuncle and carbuncle	0.026	0.974
F99-F99 Unspecified mental disorder	0.026	0.974
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.026	0.974
F80-F89 Disorders of psychological development	0.026	0.974
F70-F79 Mental retardation	0.026	0.974
F60-F69 Disorders of adult personality and behaviour	0.026	0.974
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.026	0.974
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.026	0.974
I05-I09 Chronic rheumatic heart diseases	0.026	0.974
H30-H36 Disorders of choroid and retina	0.026	0.974
J32 Chronic sinusitis	0.026	0.974
J80-J84 Other respiratory diseases principally affecting the interstitium	0.026	0.974
Z51.8 Other specified medical care	0.026	0.974
J30 Vasomotor and allergic rhinitis	0.026	0.974
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems	0.026	0.974
L03.1 Cellulitis of other parts of limb	0.026	0.974
G50 Disorders of trigeminal nerve	0.026	0.974
I45 Other conduction disorders	0.026	0.974
F10 Mental and behavioural disorders due to use of alcohol	0.026	0.974
G80-G83 Cerebral palsy and other paralytic syndromes	0.025	0.974
L08 Other local infections of skin and subcutaneous tissue	0.025	0.974
Z43 Attention to artificial openings	0.025	0.975
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.025	0.975
J60-J70 Lung diseases due to external agents	0.025	0.975
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.025	0.975
L95 Vasculitis limited to skin, not elsewhere classified	0.025	0.975
L94 Other localised connective tissue disorders	0.025	0.975
L93 Lupus erythematosus	0.025	0.975
L92 Granulomatous disorders of skin and subcutaneous tissue	0.025	0.975
L89 Decubitus ulcer	0.025	0.975
L87 Transepidermal elimination disorders	0.025	0.975
L85 Other epidermal thickening	0.025	0.975
L81 Other disorders of pigmentation	0.025	0.975
L88 Pyoderma gangrenosum	0.025	0.975
L86 Keratoderma in diseases classified elsewhere	0.025	0.975
L84 Corns and callosities	0.025	0.975
L83 Acanthosis nigricans	0.025	0.975
L80 Vitiligo	0.025	0.975
C78.7 Secondary malignant neoplasm of liver	0.025	0.975
G56.0 Carpal tunnel syndrome	0.025	0.975
Z51.5 Palliative care	0.025	0.975
L05 Pilonidal cyst	0.025	0.975
L04 Acute lymphadenitis	0.025	0.975
L01 Impetigo	0.025	0.975
L00 Staphylococcal scalded skin syndrome	0.025	0.975
H53 Visual disturbances	0.025	0.975
Z46 Fitting and adjustment of other devices	0.025	0.975
H40 Glaucoma	0.025	0.975
C81.9 Hodgkin's disease, unspecified	0.025	0.975
C81.7 Other Hodgkin's disease	0.025	0.975
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.025	0.975
C81.3 Lymphocytic depletion	0.025	0.975
C81.2 Mixed cellularity	0.025	0.975
C81.1 Nodular sclerosis	0.025	0.975
C81.0 Lymphocytic predominance	0.025	0.975
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.025	0.975
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.025	0.975
C82.6 Cutaneous follicle centre lymphoma	0.025	0.975
C82.5 Diffuse follicle centre lymphoma	0.025	0.975
C82.4 Follicular lymphoma grade IIIb	0.025	0.975
C82.3 Follicular lymphoma grade IIIa	0.025	0.975
C82.2 Large cell, follicular	0.025	0.975
C82.1 Mixed small cleaved and large cell, follicular	0.025	0.975
C82.0 Small cleaved cell, follicular	0.025	0.975
C84.9 Mature T/NK-cell lymphoma, unspecified	0.025	0.975
C84.8 Cutaneous T-cell lymphoma, unspecified	0.025	0.975
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.025	0.975
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.025	0.975
C84.5 Other and unspecified T-cell lymphomas	0.025	0.975
C84.4 Peripheral T-cell lymphoma	0.025	0.975
C84.3 Lymphoepithelioid lymphoma	0.025	0.975
C84.2 T-zone lymphoma	0.025	0.975
C84.1 Sezary's diease	0.025	0.975
C84.0 Mycosis fungoides	0.025	0.975
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.025	0.975
C86.5 Angioimmunoblastic T-cell lymphoma	0.025	0.975
C86.4 Blastic NK-cell lymphoma	0.025	0.975
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.025	0.975
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.025	0.975
C86.1 Hepatosplenic T-cell lymphoma	0.025	0.975
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.025	0.975
C88.9 Malignant immunoproliferative disease, unspecified	0.025	0.975
C88.7 Other malignant immunoproliferative diseases	0.025	0.975
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.025	0.975
C88.3 Immunoproliferative small intestinal disease	0.025	0.975
C88.2 Gamma heavy chain disease	0.025	0.975
C88.1 Alpha heavy chain disease	0.025	0.975
C88.0 Waldenstrom's macroglobulinaemia	0.025	0.975
C90.3 Solitary plasmacytoma	0.025	0.975
C90.2 Plasmacytoma, extramedullary	0.025	0.975
C90.1 Plasma cell leukaemia	0.025	0.975
C90.0 Multiple myeloma	0.025	0.975
C91.9 Lymphoid leukaemia, unspecified	0.025	0.975
C91.8 Mature B-cell leukaemia Burkitt-type	0.025	0.975
C91.7 Other lymphoid leukaemia	0.025	0.975
C91.6 Prolymphocytic leukaemia of T-cell type	0.025	0.975
C91.5 Adult T-cell leukaemia	0.025	0.975
C91.4 Hairy-cell leukaemia	0.025	0.975
C91.3 Prolymphocytic leukaemia	0.025	0.975
C91.2 Subacute lymphocytic leukaemia	0.025	0.975
C91.1 Chronic lymphocytic leukaemia	0.025	0.975
C91.0 Acute lymphoblastic leukaemia	0.025	0.975
C92.9 Myeloid leukaemia, unspecified	0.025	0.975
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.025	0.975
C92.7 Other myeloid leukaemia	0.025	0.975
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.025	0.975
C92.5 Acute myelomonocytic leukaemia	0.025	0.975
C92.4 Acute promyelocytic leukaemia	0.025	0.975
C92.3 Myeloid sarcoma	0.025	0.975
C92.2 Subacute myeloid leukaemia	0.025	0.975
C92.1 Chronic myeloid leukaemia	0.025	0.975
C92.0 Acute myeloid leukaemia	0.025	0.975
C93.9 Monocytic leukaemia, unspecified	0.025	0.975
C93.7 Other monocytic leukaemia	0.025	0.975
C93.3 Juvenile myelomonocytic leukaemia	0.025	0.975
C93.2 Subacute monocytic leukaemia	0.025	0.975
C93.1 Chronic monocytic leukaemia	0.025	0.975
C93.0 Acute monocytic leukaemia	0.025	0.975
C94.7 Other specified leukaemias	0.025	0.975
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.025	0.975
C94.5 Acute myelofibrosis	0.025	0.975
C94.4 Acute panmyelosis	0.025	0.975
C94.3 Mast cell leukaemia	0.025	0.975
C94.2 Acute megakaryoblastic leukaemia	0.025	0.975
C94.1 Chronic erythraemia	0.025	0.975
C94.0 Acute erythraemia and erythroleukaemia	0.025	0.975
C95.9 Leukaemia, unspecified	0.025	0.975
C95.7 Other leukaemia of unspecified cell type	0.025	0.975
C95.2 Subacute leukaemia of unspecified cell type	0.025	0.975
C95.1 Chronic leukaemia of unspecified cell type	0.025	0.975
C95.0 Acute leukaemia of unspecified cell type	0.025	0.975
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.025	0.975
C96.8 Histiocytic sarcoma	0.025	0.975
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.025	0.975
C96.6 Unifocal Langerhans-cell histiocytosis	0.025	0.975
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.025	0.975
C96.4 Sarcoma of dendritic cells (accessory cells)	0.025	0.975
C96.3 True histiocytic lymphoma	0.025	0.975
C96.2 Malignant mast cell tumour	0.025	0.975
C96.1 Malignant histiocytosis	0.025	0.975
C96.0 Letterer-Siwe disease	0.025	0.975
D41.9 Urinary organ, unspecified	0.025	0.975
D41.7 Other urinary organs	0.025	0.975
D41.3 Urethra	0.025	0.975
D41.2 Ureter	0.025	0.975
D41.1 Renal pelvis	0.025	0.975
D41.0 Kidney	0.025	0.975
I00-I02 Acute rheumatic fever	0.025	0.975
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium	0.025	0.975
Chapter IV Endocrine, nutritional and metabolic diseases	0.025	0.975
D63 Anaemia in chronic diseases classified elsewhere	0.025	0.975
D61 Other aplastic anaemias	0.025	0.975
D60 Acquired pure red cell aplasia [erythroblastopenia]	0.025	0.975
D62 Acute posthaemorrhagic anaemia	0.025	0.975
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.025	0.975
O20-O29 Other maternal disorders predominantly related to pregnancy	0.025	0.975
L91 Hypertrophic disorders of skin	0.025	0.975
Chapter XIV Diseases of the genitourinary system	0.025	0.975
J95-J99 Other diseases of the respiratory system	0.025	0.975
G55 Nerve root and plexus compressions in diseases classified elsewhere	0.025	0.975
L29 Pruritus	0.025	0.975
L28 Lichen simplex chronicus and prurigo	0.025	0.975
L27 Dermatitis due to substances taken internally	0.025	0.975
L25 Unspecified contact dermatitis	0.025	0.975
L24 Irritant contact dermatitis	0.025	0.975
L23 Allergic contact dermatitis	0.025	0.975
L21 Seborrhoeic dermatitis	0.025	0.975
L20 Atopic dermatitis	0.025	0.975
L26 Exfoliative dermatitis	0.025	0.975
L22 Diaper [napkin] dermatitis	0.025	0.975
J31 Chronic rhinitis, nasopharyngitis and pharyngitis	0.025	0.975

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations